MILFORD, Mass., June 23 (Bernama-BUSINESS WIRE) -- Waters
Corporation (NYSE:WAT) today announced a joint effort with the
Bioprocessing Technology Institute (BTI), a research institute within
Singapore's Agency for Science, Technology and Research (A*STAR), to
develop new methods of finding cancer markers and elucidating
glycosylation pathways that could pave the way for new therapeutic
strategies.
As part of the research collaboration, Waters and BTI will develop a glycosphingolipid (GSL) head group database containing glucose unit (GU) retention times1 and collision cross-section (CCS) values in an effort to compile an experimental library for disease-related GSL glycans together with a glycan/MS spectral library.
http://mrem.bernama.com/viewsm.php?idm=27026
As part of the research collaboration, Waters and BTI will develop a glycosphingolipid (GSL) head group database containing glucose unit (GU) retention times1 and collision cross-section (CCS) values in an effort to compile an experimental library for disease-related GSL glycans together with a glycan/MS spectral library.
No comments:
Post a Comment